Elicio Therapeutics Prices $15 Million Registered Direct Offering at $3.43; Signs Purchase, Placement Pacts
Elicio Therapeutics announced a $15 million registered direct offering of 4,380,313 common shares at $3.43 per share, expected to close on July 6, 2026. The company entered a Securities Purchase Agreement with institutional investors and a separate Placement Agency Agreement appointing Titan Partne…